ONESOURCE — Onesource Specialty Pharma Share Price
Last trade - 00:00- IN₹161.44bn
- IN₹175.28bn
- IN₹14.22bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.92 | ||
| PEG Ratio (f) | 0.32 | ||
| EPS Growth (f) | 227.84% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.77 | ||
| Price to Tang. Book | 30.79 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.46 | ||
| EV to EBITDA | 53.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.66% | ||
| Return on Equity | -0.83% | ||
| Operating Margin | 2.9% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 387.14 | 1,719.19 | 14,448.53 | 14,215.9 | 22,532 | 34,019.25 | 232.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +106.24 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Directors
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- June 12th, 2007
- Public Since
- January 24th, 2025
- No. of Shareholders
- 81,800
- No. of Employees
- 1,674
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 114,673,791
- Address
- BANGALORE, 560076
- Web
- https://www.onesourcecdmo.com/
- Phone
- +91 8067840738
- Contact
- Anurag Bhagania
- Auditors
- Deloitte Haskins & Sells
Latest News for ONESOURCE
Upcoming Events for ONESOURCE
Q2 2027 Onesource Specialty Pharma Ltd Earnings Release
Q3 2027 Onesource Specialty Pharma Ltd Earnings Release
Similar to ONESOURCE
Biocon
National Stock Exchange of India
Indo US Bio-Tech
National Stock Exchange of India
Rubicon Research
National Stock Exchange of India
Shree Ganesh Remedies
National Stock Exchange of India
Suven Life Sciences
National Stock Exchange of India
FAQ
As of Today at 04:30 UTC, shares in Onesource Specialty Pharma are trading at IN₹1,407.80. This share price information is delayed by 15 minutes.
Shares in Onesource Specialty Pharma last closed at IN₹1,407.80 and the price had moved by -23.76% over the past 365 days. In terms of relative price strength the Onesource Specialty Pharma share price has underperformed the S&P BSE 100 Index by -17.25% over the past year.
The overall consensus recommendation for Onesource Specialty Pharma is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreOnesource Specialty Pharma does not currently pay a dividend.
Onesource Specialty Pharma does not currently pay a dividend.
Onesource Specialty Pharma does not currently pay a dividend.
To buy shares in Onesource Specialty Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,407.80, shares in Onesource Specialty Pharma had a market capitalisation of IN₹161.44bn.
Here are the trading details for Onesource Specialty Pharma:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ONESOURCE
Based on an overall assessment of its quality, value and momentum Onesource Specialty Pharma is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Onesource Specialty Pharma is IN₹2,056.00. That is 46.04% above the last closing price of IN₹1,407.80.
Analysts covering Onesource Specialty Pharma currently have a consensus Earnings Per Share (EPS) forecast of IN₹40.60 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Onesource Specialty Pharma. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -4.91%.
As of the last closing price of IN₹1,407.80, shares in Onesource Specialty Pharma were trading -10.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Onesource Specialty Pharma PE ratio based on its reported earnings over the past 12 months is 21.92. The shares last closed at IN₹1,407.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Onesource Specialty Pharma's directors